A Single-Center, Double-Masked, Randomized, Vehicle Controlled Study to Evaluate the Safety and Efficacy of Testosterone 0.03% Ophthalmic Solution Compared to Vehicle for the Treatment of Meibomian Gland Dysfunction
This study is enrolling participants by invitation only.
Study NCT00755183
Information provided by ORA, Inc.
First Received: September 17, 2008
No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
